Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Capital Employed (2021 - 2025)

Oncology Institute (TOI) has disclosed Return on Capital Employed for 6 consecutive years, with 0.43% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.43%, compared with a TTM value of 0.43% through Sep 2025, changed N/A, and an annual FY2024 reading of 0.43%, down 5.0% over the prior year.
  • Return on Capital Employed was 0.43% for Q3 2025 at Oncology Institute, up from 0.48% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.05% in Q2 2021 and bottomed at 0.49% in Q2 2022.
  • Average Return on Capital Employed over 5 years is 0.34%, with a median of 0.41% recorded in 2024.
  • The sharpest move saw Return on Capital Employed plummeted -44bps in 2022, then fell -6bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.24% in 2021, then plummeted by -39bps to 0.34% in 2022, then dropped by -28bps to 0.43% in 2023, then dropped by -13bps to 0.49% in 2024, then rose by 12bps to 0.43% in 2025.
  • Business Quant data shows Return on Capital Employed for TOI at 0.43% in Q3 2025, 0.48% in Q2 2025, and 0.48% in Q1 2025.